| Little Brook Nursing And Convalescent Home | |
| 78 Sliker Road, Califon, New Jersey 07830 | |
| (908) 832-2220 | |
| Name | Little Brook Nursing And Convalescent Home |
|---|---|
| Location | 78 Sliker Road, Califon, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 36 |
| Occupancy Rate | 84.17% |
| Medicare ID (CCN) | 315467 |
| Legal Business Name | Little Brook Home, Inc |
| Ownership Type | For Profit - Partnership |
| NPI Number | 1154372969 |
| Organization Name | LITTLE BROOK HOME INC. |
| Doing Business As | LITTLE BROOK NURSING AND CONVALESCENT HOME |
| Address | 78 Sliker Rd, Califon, NJ 07830 |
| Phone Number | 908-832-2220 |
News Archive
A new "smart pill" called Gelesis100 safely leads to greater weight loss in overweight and obese individuals compared with those who receive an active comparator/placebo capsule, while all subjects have similar diet and exercise instructions, an international multicenter study finds.
International Stem Cell Corporation, www.internationalstemcell.com, announced today that its new cell production facility has passed final building inspection, which will enable development and manufacturing of the company and its partners' clinical-grade stem cell products.
Survival rates in heart failure patients with reduced levels of vitamin D are lower than in patients with normal levels. This is the finding of a major study carried out at University Medical Center, Groningen, Netherlands. Results also suggest that low levels of vitamin D are associated with activation of the Renin Angiotensin System (RAS - a pivotal regulatory system in heart failure) and an altered cytokine profile.
Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range of cancers than previously thought, according to new research presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin.
Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it has moved its expanded operations to new corporate headquarters in Charleston and is hosting a Grand Opening ceremony on October 8th, 2009 at 5:30pm - 7:30pm ET
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new "smart pill" called Gelesis100 safely leads to greater weight loss in overweight and obese individuals compared with those who receive an active comparator/placebo capsule, while all subjects have similar diet and exercise instructions, an international multicenter study finds.
International Stem Cell Corporation, www.internationalstemcell.com, announced today that its new cell production facility has passed final building inspection, which will enable development and manufacturing of the company and its partners' clinical-grade stem cell products.
Survival rates in heart failure patients with reduced levels of vitamin D are lower than in patients with normal levels. This is the finding of a major study carried out at University Medical Center, Groningen, Netherlands. Results also suggest that low levels of vitamin D are associated with activation of the Renin Angiotensin System (RAS - a pivotal regulatory system in heart failure) and an altered cytokine profile.
Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range of cancers than previously thought, according to new research presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin.
Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it has moved its expanded operations to new corporate headquarters in Charleston and is hosting a Grand Opening ceremony on October 8th, 2009 at 5:30pm - 7:30pm ET
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.4 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 19.05 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.44 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.8 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 65.42 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.62 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 29.09 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 33.96 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.83 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 17.71 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 85.22 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 86.83 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 71.79 | 82.93 |
News Archive
A new "smart pill" called Gelesis100 safely leads to greater weight loss in overweight and obese individuals compared with those who receive an active comparator/placebo capsule, while all subjects have similar diet and exercise instructions, an international multicenter study finds.
International Stem Cell Corporation, www.internationalstemcell.com, announced today that its new cell production facility has passed final building inspection, which will enable development and manufacturing of the company and its partners' clinical-grade stem cell products.
Survival rates in heart failure patients with reduced levels of vitamin D are lower than in patients with normal levels. This is the finding of a major study carried out at University Medical Center, Groningen, Netherlands. Results also suggest that low levels of vitamin D are associated with activation of the Renin Angiotensin System (RAS - a pivotal regulatory system in heart failure) and an altered cytokine profile.
Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range of cancers than previously thought, according to new research presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin.
Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it has moved its expanded operations to new corporate headquarters in Charleston and is hosting a Grand Opening ceremony on October 8th, 2009 at 5:30pm - 7:30pm ET
› Verified 8 days ago
Little Brook Nursing And Convalescent Home Location: 78 Sliker Road, Califon, New Jersey 07830 Phone: (908) 832-2220 |